Objective: This study investigated and analyzed Iranian clinical trials registered in the ICTRP portal by the end of 2015. The goal was to determine which diseases are currently being studied and whether these are diseases that carry the greatest burden of disease according to regional and WHO statistics.
Materials And Methods: Information on clinical trials carried out in Iran was downloaded from the portal of the International Clinical Trials Registry website. By the end of 2015, 10,341 studies were registered from Iran. After removing duplicate and observational studies, 10,211 studies remained for analysis. The 2016 edition of the International Classification of Diseases was used to classify the diseases.
Results: The frequency of studies was found to be mental and behavioral disorders (10.44%), diseases of the genitourinary system (10.2%), and endocrine, nutritional, and metabolic diseases (10.01%). Gastrointestinal and dermatologic diseases made up more than 12% of studies, but bear only 0.84% of the burden of disease in Iran.
Conclusion: The results showed that, despite an increase in registration of clinical trials in Iran, most studies registered were conducted on diseases, which form only a small percentage of the total disease burden of the country.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jebm.12248 | DOI Listing |
Sci Rep
December 2024
Physical Therapy Department, Rehabilitation Faculty, Tehran University of Medical Sciences, Tehran, Iran.
The study aimed to determine if virtual reality (VR) games could enhance neuromuscular control and improve anticipatory and compensatory strategies in ball-kicking for soccer players. It was a single-blind randomized clinical trial involving 32 male soccer players with chronic ankle instability. Participants were divided into two groups: VR games and balance training.
View Article and Find Full Text PDFSci Rep
December 2024
Department of Pediatric Dentistry, Faculty of Dentistry, Damascus University, Damascus, Syrian Arab Republic.
This study aimed to evaluate the histological success of pulpotomy in primary molars using white mineral trioxide aggregate (WMTA) mixed with 2.25% sodium hypochlorite (NaOCl) gel and to evaluate in vitro its physical and chemical properties. The study had a clinical stage and an in-vitro stage.
View Article and Find Full Text PDFAesthetic Plast Surg
December 2024
Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea.
Sci Rep
December 2024
School of Public Health, Chongqing Medical University, 1 Yixueyuan Road, Yuzhong District, Chongqing, 400016, China.
The study aims to address the critical issue of toxic side effects resulting from drug combinations, which can significantly increase health risks, clinical complications, and lead to drug being withdrawn from the market. A model named TSEDDI (toxic side effects of drug-drug interaction) has been developed to improve the identification of drug pairs that may induce toxicity or adverse reactions. By utilizing drug chemical structures and diverse proteins, we employ a convolutional neural network (CNN) to extract features from molecular images, enzyme proteins, transporter proteins, and target proteins.
View Article and Find Full Text PDFSci Rep
December 2024
Internal Medicine Department - Nephrology, Botucatu School of Medicine, University São Paulo State-UNESP, District of Rubiao Junior, Botucatu, Sao Paulo, Brazil.
The pharmacokinetics and pharmacodynamics (PK/PD) of vancomycin change during HD, increasing the risk of subtherapeutic concentrations. The aim of this study was to evaluate during and after the conventional and prolonged hemodialysis sessions to identify the possible risk of the patient remaining without adequate antimicrobial coverage during therapy. Randomized, non-blind clinical trial, including critically ill adults with septic AKI on conventional (4 h) and prolonged HD (6 and 10 h) and using vancomycin for at least 72 h.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!